Travere Therapeutics

TVTXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$5.780 B

$61.32 -1.81%

Close of 7 Aug 2026

Revenue

$490.7M

#1923 by revenue

Earnings

-$25.5M

Loss-making

Shares outstanding

94,261,082

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#55Ligand PharmaceuticalsLGND$5.88B
#56Amneal PharmaceuticalsAMRX$5.79B
#57Travere TherapeuticsTVTX$5.78B
#58GrifolsGRFS$5.46B
#59Acadia PharmaceuticalsACAD$5.03B

Where these numbers come from

Share counts and financials for Travere Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.